Alnylam Pharma (ALNY) Tops Q3 EPS by 8c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $147.70 --0%
Revenue Growth %: +33.0%
Financial Fact:
Total other income (expense): 2.32M
Today's EPS Names:
MFON, SICP, LBAS, More
Revenue Growth %: +33.0%
Financial Fact:
Total other income (expense): 2.32M
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.58), $0.08 better than the analyst estimate of ($1.66). Revenue for the quarter came in at $125.9 million versus the consensus estimate of $120.75 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
- Northern Trust (NTRS) Misses Q1 EPS by 49c
- Commerce Bancshares (CBSH) Tops Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
